Annual EBIT
-$104.31 M
-$5.04 M-5.08%
December 31, 2023
Summary
- As of February 7, 2025, SLDB annual earnings before interest & taxes is -$104.31 million, with the most recent change of -$5.04 million (-5.08%) on December 31, 2023.
- During the last 3 years, SLDB annual EBIT has fallen by -$17.85 million (-20.65%).
- SLDB annual EBIT is now -1489.20% below its all-time high of -$6.56 million, reached on December 31, 2015.
Performance
SLDB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$32.64 M
-$7.66 M-30.66%
September 30, 2024
Summary
- As of February 7, 2025, SLDB quarterly earnings before interest & taxes is -$32.64 million, with the most recent change of -$7.66 million (-30.66%) on September 30, 2024.
- Over the past year, SLDB quarterly EBIT has dropped by -$3.67 million (-12.66%).
- SLDB quarterly EBIT is now -274.30% below its all-time high of -$8.72 million, reached on December 31, 2016.
Performance
SLDB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$110.81 M
-$11.77 M-11.88%
September 30, 2024
Summary
- As of February 7, 2025, SLDB TTM earnings before interest & taxes is -$110.81 million, with the most recent change of -$11.77 million (-11.88%) on September 30, 2024.
- Over the past year, SLDB TTM EBIT has dropped by -$6.49 million (-6.23%).
- SLDB TTM EBIT is now -1170.61% below its all-time high of -$8.72 million, reached on December 31, 2016.
Performance
SLDB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SLDB EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.1% | -12.7% | -6.2% |
| 3 y3 years | -20.6% | -33.1% | -6.0% |
| 5 y5 years | -37.8% | -33.1% | -6.0% |
SLDB EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.4% | at low | -75.0% | at low | -53.4% | at low |
| 5 y | 5-year | -44.4% | +12.6% | -93.3% | at low | -53.4% | +7.1% |
| alltime | all time | -1489.2% | +12.6% | -274.3% | at low | -1170.6% | +7.1% |
Solid Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$32.64 M(+30.7%) | -$110.81 M(+11.9%) |
| Jun 2024 | - | -$24.98 M(+3.2%) | -$99.04 M(+0.5%) |
| Mar 2024 | - | -$24.21 M(-16.5%) | -$98.58 M(-5.5%) |
| Dec 2023 | -$104.31 M(+5.1%) | -$28.98 M(+38.8%) | -$104.32 M(+0.1%) |
| Sep 2023 | - | -$20.87 M(-14.9%) | -$104.25 M(-0.2%) |
| Jun 2023 | - | -$24.52 M(-18.1%) | -$104.51 M(+0.6%) |
| Mar 2023 | - | -$29.95 M(+3.6%) | -$103.85 M(+4.6%) |
| Dec 2022 | -$99.27 M(+37.4%) | -$28.91 M(+36.8%) | -$99.27 M(+11.5%) |
| Sep 2022 | - | -$21.13 M(-11.4%) | -$89.02 M(+3.6%) |
| Jun 2022 | - | -$23.86 M(-6.0%) | -$85.92 M(+6.4%) |
| Mar 2022 | - | -$25.37 M(+36.0%) | -$80.74 M(+11.7%) |
| Dec 2021 | -$72.25 M(-16.4%) | -$18.65 M(+3.4%) | -$72.25 M(-3.6%) |
| Sep 2021 | - | -$18.03 M(-3.5%) | -$74.95 M(-4.1%) |
| Jun 2021 | - | -$18.68 M(+10.7%) | -$78.14 M(-0.4%) |
| Mar 2021 | - | -$16.89 M(-20.9%) | -$78.43 M(-9.3%) |
| Dec 2020 | -$86.46 M | -$21.35 M(+0.6%) | -$86.46 M(-11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$21.23 M(+11.9%) | -$97.44 M(-8.0%) |
| Jun 2020 | - | -$18.97 M(-23.8%) | -$105.94 M(-7.0%) |
| Mar 2020 | - | -$24.91 M(-22.9%) | -$113.93 M(-4.5%) |
| Dec 2019 | -$119.32 M(+57.6%) | -$32.33 M(+8.8%) | -$119.32 M(+9.1%) |
| Sep 2019 | - | -$29.72 M(+10.2%) | -$109.37 M(+10.7%) |
| Jun 2019 | - | -$26.97 M(-11.0%) | -$98.81 M(+9.8%) |
| Mar 2019 | - | -$30.30 M(+35.4%) | -$90.02 M(+18.9%) |
| Dec 2018 | -$75.69 M(+38.0%) | -$22.39 M(+16.9%) | -$75.69 M(+10.6%) |
| Sep 2018 | - | -$19.15 M(+5.3%) | -$68.46 M(+8.7%) |
| Jun 2018 | - | -$18.18 M(+13.8%) | -$63.01 M(+11.1%) |
| Mar 2018 | - | -$15.97 M(+5.4%) | -$56.72 M(+3.4%) |
| Dec 2017 | -$54.86 M(+114.5%) | -$15.16 M(+10.7%) | -$54.86 M(+13.3%) |
| Sep 2017 | - | -$13.70 M(+15.2%) | -$48.42 M(+39.4%) |
| Jun 2017 | - | -$11.89 M(-15.8%) | -$34.72 M(+52.1%) |
| Mar 2017 | - | -$14.11 M(+61.8%) | -$22.83 M(+161.8%) |
| Dec 2016 | -$25.58 M(+289.6%) | -$8.72 M | -$8.72 M |
| Dec 2015 | -$6.56 M | - | - |
FAQ
- What is Solid Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Solid Biosciences?
- What is Solid Biosciences annual EBIT year-on-year change?
- What is Solid Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Solid Biosciences?
- What is Solid Biosciences quarterly EBIT year-on-year change?
- What is Solid Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Solid Biosciences?
- What is Solid Biosciences TTM EBIT year-on-year change?
What is Solid Biosciences annual earnings before interest & taxes?
The current annual EBIT of SLDB is -$104.31 M
What is the all time high annual EBIT for Solid Biosciences?
Solid Biosciences all-time high annual earnings before interest & taxes is -$6.56 M
What is Solid Biosciences annual EBIT year-on-year change?
Over the past year, SLDB annual earnings before interest & taxes has changed by -$5.04 M (-5.08%)
What is Solid Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of SLDB is -$32.64 M
What is the all time high quarterly EBIT for Solid Biosciences?
Solid Biosciences all-time high quarterly earnings before interest & taxes is -$8.72 M
What is Solid Biosciences quarterly EBIT year-on-year change?
Over the past year, SLDB quarterly earnings before interest & taxes has changed by -$3.67 M (-12.66%)
What is Solid Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of SLDB is -$110.81 M
What is the all time high TTM EBIT for Solid Biosciences?
Solid Biosciences all-time high TTM earnings before interest & taxes is -$8.72 M
What is Solid Biosciences TTM EBIT year-on-year change?
Over the past year, SLDB TTM earnings before interest & taxes has changed by -$6.49 M (-6.23%)